GlassScriptPhysician profile
Amy Lea Blevins
NPI 1689247553
$1,706.05
in general payments reported to CMS, 2019-2025
18 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $236 · 2023: $572 · 2024: $429 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $713.89 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $208.20 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $167.07 | 2021-2024 | Belbuca |
| Penumbra, INC. | $149.92 | 2025 | Indigo System |
| Medtronic, INC. | $133.95 | 2021-2025 | Intellis Adaptivestim, Concertotm |
| Biodelivery Sciences International, INC. | $60.68 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $42.23 | 2021-2022 | |
| Curonix LLC | $34.25 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $32.78 | 2022 | |
| Stimwave Technologies Incorporated | $27.83 | 2022 | |
| Averitas Pharma INC. | $22.49 | 2023 | Qutenza |
| Abbvie INC. | $21.31 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $17.44 | 2024 | |
| Redhill Biopharma INC. | $15.94 | 2021 | |
| Amgen INC. | $15.93 | 2023 | Prolia, Evenity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.27 | 2022 | |
| Tersera Therapeutics LLC | $14.42 | 2023 | Prialt |
| Horizon Therapeutics Plc | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Blevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.